BF

Berkeley Frontier Fund

North America, California, United States, Berkeley

Description

Berkeley Frontier Fund provides growth-stage funding to companies emerging out of the University of California campus.

Investor Profile

Berkeley Frontier Fund has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series E, Series F rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series C (33%)
  • Series E (33%)
  • Series F (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Computer
  • Hardware
  • Information Technology
  • Semiconductor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Berkeley Frontier Fund frequently co-invest with?

UCB Ventures
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
CA
North America, Massachusetts, United States, Boston
Co-Investments: 2
EC
North America, New York, United States, New York
Co-Investments: 2
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
UI
North America, California, United States, Oakland
Co-Investments: 2
Viking Global Investors
North America, Connecticut, United States, Stamford
Co-Investments: 2
LYFE Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Schroders Capital
Europe, England, United Kingdom, London
Co-Investments: 2
Spur Capital Partners
North America, Oklahoma, United States, Bartlesville
Co-Investments: 2
The Column Group
North America, California, United States, San Francisco
Co-Investments: 2

What are some of recent deals done by Berkeley Frontier Fund?

Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series FApr 3, 2025
Amount Raised: $102,000,000
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series EFeb 8, 2024
Amount Raised: $120,000,000
Ayar Labs

Emeryville, California, United States

Ayar Labs develops an optical I/O solution for applications that require high bandwidth and low latency using light to move data.

ComputerHardwareInformation TechnologySemiconductor
Series CApr 26, 2022
Amount Raised: $130,000,000